InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-14.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Robert W. Shaw, Director. Insider active across 1 company, notably Ultralife CORP. Aggregated, 5 reports have been recorded. Split: 5 buys · 0 sell. Total volume traded: €80k. Activity tracked since 7 February 2022. The latest transaction was filed on 24 November 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Robert W. Shaw
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
1,750 shares@ US$5.6710.8% of flowCommon Stock; $.10 par valueSEC:0001437749-25-036397:0
Canonical exit: 22 Feb 2026 (T+90)
4,000 shares@ US$5.4923.3% of flowCommon Stock; $.10 par valueSEC:0001437749-25-016753:0
Canonical exit: 12 Aug 2025 (T+90)
2,500 shares@ US$7.9122.0% of flowCommon Stock; $.10 par valueSEC:0001437749-24-034590:0
Canonical exit: 10 Feb 2025 (T+90)
2,000 shares@ US$10.2942.0% of flowCommon Stock; $.10 par valueSEC:0001437749-23-025961:0
Canonical exit: 13 Dec 2023 (T+90)
3,000 shares@ US$5.100.014% mcap50.0% of flowCommon Stock; $.10 par valueSEC:0001437749-22-002672:0
Canonical exit: 8 May 2022 (T+90)
5 of 5 declarations
About Robert W. Shaw
Robert W. Shaw serves as a Director at ULTRALIFE CORP. He brings his expertise in corporate governance and strategy. His role as a director includes participating in board meetings and contributing to strategic decision-making for the company.
